Improving Quantification of Residual Host Cell and Mycoplasma Contaminant DNA for Cell and Gene Therapies with ddPCR™ Technology
Traditional testing techniques for residual host cell DNA and mycoplasma contaminants fall short of the stringent requirements set by regulatory bodies